IP Verse

Wuesthoff & Wuesthoff Patentanwalte Partg Mbb patent opposition analysis

Get complete Patent Opposition Report for Wuesthoff & Wuesthoff Patentanwalte Partg Mbb

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Latest oppositions filed by Wuesthoff & Wuesthoff Patentanwalte Partg Mbb

Explore patent oppositions filed by Wuesthoff & Wuesthoff Patentanwalte Partg Mbb against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent Number	Title	Applicant	Opposition Date
EP3380121	Methods For Treating Eye Disorders	ACCELERON PHARMA	Sep 18, 2024
EP2967015	Transgenic Mice Expressing Chimeric Major Histocompatibility Complex (Mhc) Class Ii Molecules	REGENERON PHARMACEUTICALS	Mar 5, 2024
EP2508188	Pharmaceutical Formulations Containing Dapagliflozin Propylene Glycol Hydrate	ASTRAZENECA	Feb 6, 2024
EP3363811	Method For Producing Fusion Protein Having Igg Fc Domain	ALTEOGEN	Jan 17, 2024
EP3463180	Apparatus And Methods For Receiving Discharged Urine	FOREHAND	Dec 29, 2023
EP3067043	Pharmaceutical Compositions Based On Superstructures Of Angiotensin Receptor Antagonist/Blocker (Arb) And Neutral Endopeptidase (Nep) Inhibitor	NOVARTIS	Aug 16, 2023
EP3199952	Method For Measuring Reactivity Of Fviii	CHUGAI SEIYAKU KABUSHIKI KAISHA	Jul 26, 2023
EP2247751	Disease Resistant Pepper Plants	HAZERA GENETICS	Jul 5, 2023
EP2959894	S1P Receptor Modulators For Treating Multiple Sclerosis	NOVARTIS	May 10, 2023
EP3716992	Use Of A Vegf Antagonist To Treat Angiogenic Eye Disorders	REGENERON PHARMACEUTICALS	May 5, 2023

Top competitors of Wuesthoff & Wuesthoff Patentanwalte Partg Mbb

NOVARTIS

MERCK SHARP & DOHME

REGENERON PHARMACEUTICALS